Avenue therapeutics to host virtual key opinion leader (kol) event on april 4, 2024

Miami, march 25, 2024 (globe newswire) -- avenue therapeutics, inc. (nasdaq: atxi) (“avenue” or the “company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that it will host a virtual key opinion leader (“kol”) event highlighting expert perspectives on spinal bulbar muscular atrophy (“sbma”), also known as kennedy's disease, on thursday, april 4, 2024 at 11:00am et.
ATXI Ratings Summary
ATXI Quant Ranking